Rani Therapeutics Holdings, Inc. - 8-K Filing

Rani Therapeutics transfers listing to Nasdaq Capital Market and receives extension to regain minimum bid price compliance. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing)

SEC EDGAR · November 12, 2026, 21:20 UTC

Tickers: $RANI

Read the full article at SEC EDGAR

More Regulatory news

FACT II Acquisition Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:46 UTC
Marblegate Capital Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 21:46 UTC
Greenland Mines Ltd - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
InspireMD, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
InspireMD, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
Pinnacle Acquisition Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 21:45 UTC
SUTRO BIOPHARMA, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
Aeluma, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
ASTEC INDUSTRIES INC - 8-K Filing SEC EDGAR · November 12, 2026, 21:45 UTC
Live Oak Bancshares, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:44 UTC